Ascent Assurance was renamed USHEALTH Group in March 2005. The company was founded in 1982 in Fort Worth, Texas. The headquarters of USHEALTH Group is in Dallas, Texas. USHEALTH Group is a family of health insurance companies that offer quality services to its clients. They cover a wide range of areas including dental covers, life [Continue]
According to the US Center for Disease Control over 2.6 million people die each year. The sad truth with these statistics is that of these deaths, at least seven out of ten are as a result of chronic and genetic diseases that could be treated in advance hence saving the lives of the victims. [Continue]
Mikhail Blagosklonny, is an oncology professor at Roswell Park Cancer Institute in New York. He began his career with Roswell in 2009 and brought extensive experience and skill with him. His research includes cancer, cancer targeted therapies, aging, and anti-aging drugs. Through his research, he has developed a hypothesis regarding TOR signaling in aging as [Continue]
Copa star is a world-class hospital providing quality and sound services to patients using the latest technology. The healthcare facility specializes in offering comprehensive services that include neurosurgery and heart surgeries among others. The construction of this hospital was inspired by the need of specialized services in Rio de Janeiro to cater for World Cup [Continue]
Oncotarget can be considered as being a primary source of learning for anybody. The website has been made to specifically enable people to take advantage of an opportunity in which they can share ideas by communicating with one another. Scholarly articles in the field of science are also uploaded weekly. It is important to note [Continue]
JeanMarie Guenot, Ph.D., is currently the President and Chief Executive Officer of Amphivena Therapeutics, Inc., which started operating in July of 2013. This innovative company is developing antibody bifunctional therapies for hematologic malignancies. Its mission is to eradicate cancers of the blood with the use of a breakthrough therapy harnessing the immune system [Continue]